Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News
Xconomy
JULY 15, 2016
Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. After last week’s revelation of three patient deaths in its leading cancer immunotherapy trial, the FDA suspended the study. The week started on a reflective note.
Let's personalize your content